Literature DB >> 15715682

Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study.

J K Virtanen1, S Voutilainen, G Alfthan, M J Korhonen, T H Rissanen, J Mursu, G A Kaplan, J T Salonen.   

Abstract

OBJECTIVE: Based on case-control and prospective studies elevated blood total homocysteine (tHcy) has been suggested to be an independent risk factor for cardiovascular diseases (CVD). The purpose of the study was to explore the joint effect of increased serum tHcy concentration and other risk factors on the risk of CVD mortality in middle-aged men without a history of heart disease or stroke.
DESIGN: A prospective, population-based Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study.
SETTING: Eastern Finland. Subjects. A total of 802 men aged 46-64 years, examined in 1991-93. MAIN OUTCOME MEASURES: CVD mortality event.
RESULTS: The mean serum tHcy concentration was 10.8 micromol L(-1) (SD 3.3). During the average follow-up time of 10.8 years 50 men experienced a CVD death. The hazard rate ratio for CVD mortality was 1.80 (95% confidence interval: 1.02-3.19) in men in the highest serum tHcy third versus lower thirds after adjustment for cardiovascular risk factors. Furthermore, elevated serum tHcy concentration appeared to increase the risk of CVD death in men who smoke or who have high circulating concentrations of serum total or LDL cholesterol, apo-B apolipoprotein or plasma fibrinogen.
CONCLUSION: We conclude that homocysteine may increase the risk of CVD mortality in middle-aged men from Eastern Finland, and it may especially increase the risk when present with other risk factors for CVD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715682     DOI: 10.1111/j.1365-2796.2005.01450.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over.

Authors:  Christopher J Bates; Mohammed A Mansoor; Kristina D Pentieva; Mark Hamer; Gita D Mishra
Journal:  Br J Nutr       Date:  2010-04-19       Impact factor: 3.718

2.  Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.

Authors:  Yusuf I Alihanoglu; Bekir S Yildiz; Emin E Özcan; Ismail D Kilic; Deniz S Kuru; Ozgur Taskoylu; Halil Tanriverdi; Havane A Kaftan; Harun Evrengul
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

3.  Factors associated with the steep increase in late-midlife stroke occurrence among US men.

Authors:  Amytis Towfighi; Jeffrey L Saver; Rita Engelhardt; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Jul-Aug       Impact factor: 2.136

4.  Methylenetetrahydrofolate reductase gene polymorphism in diabetes and obesity.

Authors:  Javad Tavakkoly Bazzaz; Mahnaz Shojapoor; Habibollah Nazem; Parvin Amiri; Hossein Fakhrzadeh; Ramin Heshmat; Maryam Parvizi; Shirin Hasani Ranjbar; Mahsa M Amoli
Journal:  Mol Biol Rep       Date:  2009-05-13       Impact factor: 2.316

5.  The Effects of Acute Exercise and Exercise Training on Plasma Homocysteine: A Meta-Analysis.

Authors:  Rafael Deminice; Diogo Farias Ribeiro; Fernando Tadeu Trevisan Frajacomo
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Classical homocystinuria, is it safe to exercise?

Authors:  Aurel T Tankeu; Geraldine Van Winckel; Belinda Campos-Xavier; Olivier Braissant; Rosette Pedro; Andrea Superti-Furga; Francesca Amati; Christel Tran
Journal:  Mol Genet Metab Rep       Date:  2021-03-26

7.  Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease.

Authors:  Chiara Bellia; Giulia Bivona; Concetta Scazzone; Marcello Ciaccio
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

8.  Economic recession and cardiovascular disease among women: a cohort study from Eastern Finland.

Authors:  Rand Jarroch; Tomi-Pekka Tuomainen; Behnam Tajik; Jussi Kauhanen
Journal:  Scand J Public Health       Date:  2021-02-10       Impact factor: 3.021

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.